Please note: This trial has finished recruiting and is not accepting new participants.

Research Center: Griffith University
Location: Griffith Health Centre, Building G40, Griffith University, Gold Coast Campus, Parklands Drive, Southport (shown on map)
Lead Doctors: Professor Michael Goode and Dr Danielle Stanisic   
Ethics Committee: Reviewed and approved by the Griffith University Human Research Ethics Committee

Background

Although current malaria treatments are effective in most cases, it is estimated that there are up to 1 million deaths from malaria each year, mostly in pregnant women, and children under the age of 5.

Unfortunately, anti-malarial drugs and eradication of mosquitos by insecticides are becoming less effective due to the development of drug and insecticide resistance.

This trial involves studying Malaria infection, and is a precursor to a malaria vaccine trial. Participants will be closely monitored and given anti-malarial medication to completely eradicate the early stage infection before experiencing any symptoms. The study is being funded by 2 philanthropic organizations: The Atlantic Philanthropies and the Merchant Foundation.

Benefits of Participation

• You will be compensated up to $700.
• You will be helping the development of a Malaria vaccine.
• Qualified health professionals will monitor your health.
• You will be helping to advance medical research.

Your Rights

• If you decide to participate in the study and later feel that you no longer wish to be part of it, you may withdraw at any time.
• Your records relating to this study and any other information received will be kept strictly confidential.
• Upon completion, the results of the study will be shared with you.

Who Can Participate?

• Males aged 18 to 45.
• Have a BMI of between 18 and 30kg/m².
• Are a non-smoker
• Have never had Malaria.